The present invention relates to co-crystal of levomilnacipran hydrochloride and amino acid and process for preparation thereof. The invention also relates to pharmaceutical composition comprising therapeutically effective amount of said co-crystal together with one or more pharmaceutically acceptable excipients for the treatment of major depressive disorder (MDD) Formula (B)